| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | -0.0058 | 0.9 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | -0.0054 | 0.9 |
| mRNA | CH5424802 | GDSC1000 | pan-cancer | AAC | 0.0034 | 0.9 |
| mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | -0.0035 | 0.9 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | -0.0047 | 0.9 |
| mRNA | BRD-A02303741 | CTRPv2 | pan-cancer | AAC | -0.0035 | 0.9 |
| mRNA | BRD-K35604418 | CTRPv2 | pan-cancer | AAC | 0.0032 | 0.9 |
| mRNA | ML006 | CTRPv2 | pan-cancer | AAC | -0.0032 | 0.9 |
| mRNA | YM201636 | GDSC1000 | pan-cancer | AAC | 0.0027 | 0.9 |
| mRNA | BRD8958 | CTRPv2 | pan-cancer | AAC | -0.0032 | 0.9 |